Goldman Sachs’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-25,367
Closed -$14.1K 5353
2022
Q4
$14.1K Sell
25,367
-49,375
-66% -$27.4K ﹤0.01% 4922
2022
Q3
$89K Sell
74,742
-157,718
-68% -$188K ﹤0.01% 4949
2022
Q2
$147K Buy
232,460
+26,345
+13% +$16.7K ﹤0.01% 4998
2022
Q1
$235K Sell
206,115
-35,769
-15% -$40.8K ﹤0.01% 5016
2021
Q4
$544K Buy
241,884
+32,481
+16% +$73.1K ﹤0.01% 4457
2021
Q3
$716K Buy
209,403
+157,770
+306% +$539K ﹤0.01% 4186
2021
Q2
$154K Sell
51,633
-45,092
-47% -$134K ﹤0.01% 5015
2021
Q1
$312K Buy
96,725
+18,785
+24% +$60.6K ﹤0.01% 4619
2020
Q4
$165K Buy
77,940
+23,518
+43% +$49.8K ﹤0.01% 4336
2020
Q3
$64K Buy
+54,422
New +$64K ﹤0.01% 4293
2018
Q4
Sell
-33,778
Closed -$92K 4295
2018
Q3
$92K Sell
33,778
-51,084
-60% -$139K ﹤0.01% 3967
2018
Q2
$162K Buy
84,862
+7,217
+9% +$13.8K ﹤0.01% 3923
2018
Q1
$163K Sell
77,645
-72,730
-48% -$153K ﹤0.01% 3911
2017
Q4
$305K Buy
150,375
+75,980
+102% +$154K ﹤0.01% 3650
2017
Q3
$99K Sell
74,395
-171,839
-70% -$229K ﹤0.01% 4041
2017
Q2
$387K Buy
246,234
+105,497
+75% +$166K ﹤0.01% 3668
2017
Q1
$455K Sell
140,737
-72,865
-34% -$236K ﹤0.01% 3560
2016
Q4
$288K Buy
213,602
+12,468
+6% +$16.8K ﹤0.01% 3737
2016
Q3
$314K Buy
201,134
+35,258
+21% +$55K ﹤0.01% 3686
2016
Q2
$221K Sell
165,876
-1,467,369
-90% -$1.96M ﹤0.01% 3806
2016
Q1
$8.61M Sell
1,633,245
-1,290,521
-44% -$6.8M ﹤0.01% 1808
2015
Q4
$23M Sell
2,923,766
-2,462,774
-46% -$19.3M 0.01% 1281
2015
Q3
$45.5M Sell
5,386,540
-206,635
-4% -$1.75M 0.02% 867
2015
Q2
$61.2M Buy
5,593,175
+1,906,476
+52% +$20.9M 0.02% 750
2015
Q1
$51.5M Buy
3,686,699
+903,292
+32% +$12.6M 0.02% 842
2014
Q4
$47M Sell
2,783,407
-366,619
-12% -$6.19M 0.01% 850
2014
Q3
$42.3M Sell
3,150,026
-240,674
-7% -$3.23M 0.01% 880
2014
Q2
$43.2M Sell
3,390,700
-279,105
-8% -$3.56M 0.01% 895
2014
Q1
$43.6M Buy
3,669,805
+549,609
+18% +$6.53M 0.01% 848
2013
Q4
$43.1M Buy
3,120,196
+1,346,667
+76% +$18.6M 0.01% 837
2013
Q3
$30.9M Buy
1,773,529
+476,166
+37% +$8.3M 0.01% 920
2013
Q2
$21M Buy
+1,297,363
New +$21M 0.01% 1045